Export 26 results:
Author Title Type [ Year(Asc)]
Filters: Author is Blodi, Barbara A  [Clear All Filters]
2019
J. S. Peterson, Rockwell, K., Scott, I. U., Ip, M. S., VanVeldhuisen, P. C., and Blodi, B. A., LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS., Retina, vol. 39, no. 9, pp. 1802-1809, 2019.
M. S. Ip, Oden, N. L., Scott, I. U., VanVeldhuisen, P. C., Blodi, B. A., Ghuman, T., and Baker, C. W., Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study., JAMA Ophthalmol, vol. 137, no. 3, pp. 281-287, 2019.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., and Chan, C. K., Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial., JAMA Ophthalmol, 2019.
I. U. Scott, VanVeldhuisen, P. C., Barton, F., Oden, N. L., Ip, M. S., Blodi, B. A., Worrall, M., and Fish, G. E., Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial., JAMA Ophthalmol, 2019.
2017
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., King, J., Antoszyk, A. N., Peters, M. A., and Tolentino, M., Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4., JAMA Ophthalmol, vol. 135, no. 6, pp. 639-649, 2017.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Awh, C. C., Kunimoto, D. Y., Marcus, D. M., Wroblewski, J. J., and King, J., Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial., JAMA, vol. 317, no. 20, pp. 2072-2087, 2017.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Figueroa, M., and Dugel, P. U., SCORE2 Report 2: Study Design and Baseline Characteristics., Ophthalmology, vol. 124, no. 2, pp. 245-256, 2017.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Figueroa, M., and Dugel, P. U., SCORE2 Report 2: Study Design and Baseline Characteristics., Ophthalmology, vol. 124, no. 2, pp. 245-256, 2017.
I. U. Scott, Figueroa, M. J., Oden, N. L., Ip, M. S., Blodi, B. A., and VanVeldhuisen, P. C., SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion., Am J Ophthalmol, vol. 184, pp. 147-156, 2017.
2009
M. S. Ip, Scott, I. U., VanVeldhuisen, P. C., Oden, N. L., Blodi, B. A., Fisher, M., Singerman, L. J., Tolentino, M., Chan, C. K., and Gonzalez, V. H., A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlus, Arch Ophthalmol, vol. 127, no. 9, pp. 1101-14, 2009.
I. U. Scott, VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., Blodi, B. A., J Jumper, M., and Figueroa, M., SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion., Ophthalmology, vol. 116, no. 3, pp. 504-12, 2009.
I. U. Scott, Blodi, B. A., Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Chan, C. K., and Gonzalez, V., SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type., Ophthalmology, vol. 116, no. 4, pp. 756-61, 2009.
M. S. Ip, Oden, N. L., Scott, I. U., VanVeldhuisen, P. C., Blodi, B. A., Figueroa, M., Antoszyk, A., and Elman, M., SCORE Study report 3: study design and baseline characteristics., Ophthalmology, vol. 116, no. 9, pp. 1770-1777.e1, 2009.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., and Antoszyk, A. N., SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design., Am J Ophthalmol, vol. 148, no. 5, pp. 725-732.e7, 2009.